Objective-Bim is a proapoptotic Bcl-2 protein known to downregulate immune responses and to also be required for antigen-induced T-cell activation. However, it is not known how the effect of Bim on these offsetting processes determines the outcome of allogeneic immune responses. We have defined the role of Bim in regulating alloantigen-driven T-cell responses in a model of vascular rejection. Approach and Results-Bim was required for proliferation of CD4 and CD8 T cells, and for interleukin-2 production, in T cells stimulated with alloantigen in vitro. Moreover, a partial reduction in Bim expression was sufficient to attenuate T-cell activation, whereas a complete elimination of Bim was required to prevent CD4 T-cell death in response to cytokine withdrawl. When alloimmune-mediated vascular rejection was examined using an aortic interposition model, there was significantly less intimal thickening in Bim +/− , but not Bim −/− , graft recipients. T-cell proliferation in response to allograft arteries was significantly reduced in both Bim +/− and Bim −/− mice, but cell death was attenuated only in Bim −/− animals.
H eart transplantation is a life-saving procedure, but its use is limited by the eventual failure of most grafts largely because of immune-mediated processes. 1 As such, understanding the basic mechanisms by which allogeneic immune responses are regulated is essential for the development of strategies that prevent heart transplant failure. Immunologic reactions to foreign major histocompatibility complexes (MHCs) and their associated peptides on the surface of graft cells drive the activation of effector T cells in lymphoid tissues and directly in the graft. 2, 3 Effector T cells that accumulate within grafts then cause acute and chronic graft failure by targeting parenchymal and vascular cells. The aggressiveness and persistence of allogeneic effector T-cell responses is regulated by a balance between T-cell proliferation and death. 4 Specifically, defects in T-cell proliferation reduce graft-specific immune responses and resultant rejection, 5 whereas defects in T-cell death augment graft rejection and oppose the development of tolerance. [6] [7] [8] [9] [10] Bcl-2 proteins are known to control T-cell death after transplantation. Using mice in which T cells overexpress the antiapoptotic Bcl-2 protein Bcl-xL, Wells et al 6 showed that Bcl-xL increases T-cell persistence after heart transplantation, and in this way augments acute and chronic heart transplant rejection.
Bim is a proapoptotic BH3-only member of the Bcl-2 family that is a pivotal initiator of T-cell death triggered by cytokine deprivation. 11 Bim antagonizes the survival actions of Bcl-2 and Bcl-xL, thereby triggering mitochondrial permeabilization and resultant cell death. 12 In the mature immune system, Bim is required for the contraction of CD8 T-cell responses after both acute and chronic viral infection. [12] [13] [14] The importance of Bim-mediated T-cell death in immune homeostasis is highlighted by the development of certain autoimmune-like manifestations in mice that lack this protein. 11 Paradoxically, in addition to regulating T-cell death, recent evidence indicates that Bim is also required for optimal T-cell activation in autoimmune encephalomyelitis, type 1 diabetes mellitus, and graft-versus-host disease. 15, 16 However, nothing is known about how the opposing effects of Bim on T-cell activation and death cooperate to define the outcome of immunopathological conditions, whether Bim differentially affects CD4 and CD8 T-cell responses to alloantigens, and how Bim affects immune-mediated vascular injury.
Immune-mediated vascular injury is a main contributor to organ transplant failure through the induction of microvascular damage, which results in thrombosis and hemorrhage, and of macrovascular damage, which disturbs blood flow and contributes to the development of intimal thickening and pathological restructuring of allograft arteries. 17 The latter changes manifest mainly as transplant arteriosclerosis. Although there are distinctions in the acute and chronic immune responses that drive vascular injury, observations that an increased incidence of acute rejection episodes predicts a greater severity of transplant arteriosclerosis suggest an overlapping involvement of both types of immune responses to pathologically important outcomes in the graft vasculature. [18] [19] [20] [21] [22] Aspects of immunologic vascular injury and rejection that are applicable to organ transplant failure can be modeled using aortic interposition grafting in mice. Using a combination of in vitro experiments and a complete MHCmismatch model of aortic interposition grafting, we show in the current study that Bim is required for the optimal activation of both CD4 and CD8 T cells in response to allogeneic stimulation. We further identify a quantitative difference in the reliance of T cells on Bim for activation as opposed to cell death, with a partial reduction in Bim expression preventing T-cell proliferation but not death, and complete elimination of Bim expression preventing both proliferation and death. Aortic interposition grafting of artery segments into Bim +/+ , Bim +/− , and Bim −/− recipients showed that reduction of Bim expression (in Bim +/− mice), but not complete elimination (in Bim −/− mice), reduces immune-mediated vascular injury and rejection. This coincided with attenuated T-cell proliferation, but not cell death, in Bim +/− graft recipients. Both T-cell proliferation and death were attenuated in Bim −/− graft recipients, likely resulting in offsetting effects on immune activation and inactivation in this setting. Altogether, our findings provide important insight into the control of allogeneic T-cell responses and show that the effect of Bim on alloantigen-induced T-cell responses is complexly regulated by its opposing effects on T-cell proliferation and death. This has implications for understanding alloimmune-mediated vascular damage that contributes to organ transplant failure.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Bim Is Required for Alloantigen-Induced Activation of T Cells
To begin examining the role of Bim in controlling the alloantigen-induced activation of T cells, CD4 and CD8 T cells were isolated from Bim +/+ , Bim +/− , and Bim −/− mice, labeled with 5-(and -6)-carboxyfluorecein diacetate succinimidyl ester (CFSE), and then stimulated with allogeneic macrophages. Proliferation was examined by measuring CFSE dilution after 6 days. There was no proliferation in syngeneic controls but there was robust proliferation of Bim +/+ T cells in response to alloantigen stimulation. Both Bim +/− and Bim −/− CD4 T cells proliferated significantly less than Bim +/+ CD4 T cells, and the defect in proliferation was comparable between Bim +/− and Bim −/− CD4 T cells ( Figure 1A and 1B). When alloantigen-induced proliferation of CD8 T cells was examined, there was significantly less proliferation of Bim −/− CD8 T cells as compared with Bim +/+ counterparts. There also seemed to be less proliferation of Bim +/− CD8 T cells when compared with Bim +/+ cells, but these results did not reach statistical significance ( Figure 1C and 1D; P=0. 15) .
Interleukin (IL)-2 secretion from CD4 and CD8 T cells was then evaluated. No IL-2 was detected in T cells cultured with syngeneic macrophages and there was substantial IL-2 secretion by Bim +/+ T cells in response to allogeneic stimulation. There was a significant reduction in IL-2 production by both CD4 and CD8 T cells isolated from Bim +/− and Bim −/− mice in response to allogeneic stimulation as compared with cells isolated from Bim +/+ mice ( Figure 1E ). Thus, Bim is required for the optimal activation of CD4 and CD8 T cells. Moreover, profiling of Bim expression in isolated T cells indicated that cells from Bim +/− mice express ≈50% levels of this Bcl-2 protein as compared with Bim +/+ T cells ( Figure 1F ), indicating that a partial reduction in Bim expression is sufficient to attenuate alloantigen-induced T-cell activation.
Complete Elimination of Bim Expression Prevents Cytokine Deprivation-Induced T-Cell Death
Two modes of T-cell death regulate allogeneic responses: activation-induced cell death that is caused by continuous exposure of T cells to antigen stimulation and cytokine deprivation-induced cell death. 6 T-cell viability was therefore analyzed in Bim +/+ , Bim +/− , and Bim −/− T cells that were continually stimulated with allogeneic macrophages. There was no difference in the survival of CD4 or CD8 T cells in any of the groups (Figure 2A and 2B), indicating that Bim does not affect T-cell death in this setting. These findings also support a role for Bim in regulating T-cell activation that is independent of its role in controlling cell death.
In addition to activation-induced cell death, T-cell responses are also regulated by cytokine deprivation-induced cell death in transplantation. This is demonstrated by experiments showing that transplant outcome is affected by the expression of Bcl-xL (which is a key regulator of cell death in response to cytokine deprivation) in T cells. 6 This form of cell death is likely to be triggered in the setting of transplantation by local regions of reduced cytokine availability, downregulation of cytokine receptors from the surface of activated T cells, or the elimination of donor-derived antigen-presenting cells that directly present alloantigens to T cells in lymphoid tissues and the graft. As such, we characterized the role of Bim in regulating cytokine deprivation-induced cell death of CD4 and CD8 T cells using an established ex vivo protocol, which involves culturing freshly isolated T cells in the absence of T-cell receptor (TCR) or cytokine stimulation. 11, 23 Bim +/+ CD4 T cells died at a steady rate with <10% survival after 72 hours. As expected, Bim −/− CD4 T cells were significantly protected from cytokine deprivation-induced cell death. Interestingly, Nonstandard Abbreviations and Acronyms CFSE 5-(and -6)-carboxyfluorecein diacetate succinimidyl ester
T-cell receptor
Bim +/− CD4 T cells underwent cell death at an identical rate as Bim +/+ CD4 T cells, indicating that a partial reduction in Bim levels is not sufficient to attenuate cytokine deprivationinduced cell death in CD4 T cells ( Figure 2C ). Importantly, Bim +/− CD4 T cells were also significantly more susceptible to cytokine deprivation-induced cell death than Bim −/− T cells. With regard to CD8 T cells, Bim +/+ CD8 T cells underwent a steady rate of death in response to cytokine deprivation and, as expected, Bim −/− CD8 T cells were resistant to this form of cell death. However, unlike CD4 T cells, Bim +/− CD8 T cells were partially protected from cell death, undergoing levels of cell death that were intermediate between Bim +/+ and Bim −/− cells ( Figure 2D ). These results show that complete elimination of Bim expression protects both CD4 and CD8 T cells from cytokine deprivation-induced cell death, but that a partial reduction in Bim levels does not affect this cell death process in CD4 T cells and partially reduces cell death of CD8 T cells. We also examined cytokine deprivation-induced cell death of TCR-activated T cells in vitro. For this, isolated CD4 and CD8 T cells were stimulated with anti-CD3 plus anti-CD28, removed from stimulation, and further cultured in the presence of an IL-2 neutralizing antibody for 72 hours. IL-2 was neutralized because short-term stimulation of T cells in vitro is known to result in continued proliferation and cytokine secretion for several days after removal from stimulation. 24, 25 There was no difference in cell death between any of the groups before 72 hours after removal from stimulation. At 72 hours, activated CD4 T cells from Bim −/− mice were significantly protected from cell death but cells from Bim +/− mice were not. Also, activated CD4 T cells from Bim −/− mice underwent significantly less cell death than those from Bim +/− mice ( Figure 2E ). Unexpectedly, Bim did not affect CD8 T-cell death in these in vitro experiments (data not shown). This in vitro model may not reflect the in vivo response of CD8 T cells because Bim −/− CD8 T cells are firmly established as being resistant to cell death caused by cytokine deprivation in vivo. 13, 26, 27 
Partial Reduction, but Not Complete Elimination, of Bim Attenuates Immune-Mediated Vascular Rejection
The role of Bim in regulating T-cell-mediated allograft vascular damage and rejection was examined by interposition grafting of aortic segments from complete MHC-mismatched donors into Bim +/+ , Bim +/− , and Bim −/− recipients. Immune-mediated vascular injury in this model initiates vascular reparative responses that culminate in rapid intimal thickening. [28] [29] [30] The grafted arteries were harvested at day 30 post transplantation for analysis of intimal thickening, which serves as a readout for the severity of vascular injury. Artery segments transplanted into Bim +/− , but not Bim −/− mice, developed significantly less intimal thickening as compared with Bim +/+ recipients (Figure 3) .
The effect of Bim on the accumulation of leukocytes in allograft arteries was then examined by quantifying the number of CD4 and CD8 T cells and macrophages, within allograft arteries. There was significantly less CD4 T-cell accumulation in allograft arteries transplanted into Bim +/− mice as compared with Bim +/+ counterparts, but CD4 T-cell accumulation did not differ in arteries harvested from Bim −/− and Bim +/+ mice ( Figure 4A and 4B ). There was no significant difference in the accumulation of CD8 T cells ( Figure 4C and 4D) or macrophages ( Figure 4E and 4F) in allograft arteries from Bim +/+ , Bim +/− , and Bim −/− mice. Staining for dendritic cells revealed too few cells in the intima to conclusively determine differences between the groups (data not shown). The effect of Bim on vascular cells within the grafts was also determined. Endothelial cell-vessel lining and the accumulation of intimal smooth muscle cells were studied by staining sections of the allograft arteries for CD31 and smooth muscle α-actin, respectively. No significant difference was observed in EC lining of the lumen ( Figure 5A and 5B) or in amount of smooth muscle cells ( Figure 5C and 5D) in the intima of allograft arteries in any of the groups.
Partial Reduction of Bim Levels Attenuates T-Cell Proliferation, but Not Death, in Response to Allograft Arteries
Because a decrease in Bim expression levels reduced intimal thickening and attenuated the accumulation of CD4 effector T cells in allograft arteries, T-cell proliferation and death in response to allograft arteries were examined. Segments of abdominal aorta were transplanted into Bim +/+ , Bim +/− , or Bim −/− mice and splenocytes isolated at day 7 post transplant. Flow cytometric analysis was performed for CD4, CD8, CD44, Ki67, and active caspase-3 to quantify CD4 and CD8 Figure 6A and 6B) . Also, there was no difference in cell death of CD4 T cells in Bim +/− as compared with Bim +/+ artery graft recipients, but T-cell death was significantly reduced in Bim −/− mice as compared with either Bim +/+ or Bim +/− counterparts ( Figure 6C and 6D ). Proliferation of CD8 T cells was also reduced in both Bim +/− and Bim −/− mice in response to allograft arteries ( Figure 6E and 6F ). Cell death of CD8 T cells was significantly reduced only in Bim −/− as compared with Bim +/+ graft recipients ( Figure 6G and 6H) .
In addition to the manual analysis of flow cytometric data using isotype staining controls to identify positive gates, positive events in all the data were also identified using an automated, unbiased approach to eliminate potential human error and to standardize the analysis. This analysis confirmed that CD4 and CD8 T-cell proliferation was reduced in Bim +/− and Bim −/− graft recipients, respectively, and that CD4 T-cell death was reduced only in Bim −/− graft recipients (Figures I and II in the online-only Data Supplement). There was a strong trend toward a reduction in CD8 T-cell death in Bim −/− graft recipients compared with Bim +/+ counterparts (P=0.09). All together, our data show that a partial reduction in Bim expression is sufficient to attenuate T-cell proliferation but not death in response to allograft arteries, and that complete elimination of Bim attenuates both processes. Therefore, allogeneic immune responses are diminished in Bim +/− , but not Bim −/− , mice because defects in T-cell activation in the latter condition are likely offset by increased T-cell survival.
Discussion
In the current study, we have shown that Bim is required for the activation of T cells in response to stimulation by alloantigen and that this process is involved in immune-mediated vascular damage and rejection. We further report that the effect of Bim on T-cell activation and death can be separated by differential reductions in Bim levels. Specifically, a partial reduction in Bim expression, as seen in Bim +/− T cells, is sufficient to attenuate T-cell activation but complete elimination of Bim expression is required to prevent CD4 T-cell death. To our knowledge, our data are the first to demonstrate that the regulation of allogeneic immune responses by Bim is regulated by its opposing effects on T-cell activation and death and to establish a role for this Bcl-2 family member in the regulation of allograft vascular injury.
Our in vitro data show that, in response to allogeneic stimulation, both Bim +/− and Bim −/− T cells display reduced proliferation as compared with Bim +/+ cells. Interestingly, a half reduction in Bim levels, as occurs in Bim +/− T cells, is sufficient to produce this effect. Cell death was measured in these cultures and no difference was observed between any of the groups, indicating that the observed effect on the accumulation of proliferated cells was not because of altered cell survival. Because T cells in this setting are exposed to continuous antigen and there is persistent production of IL-2, cell death in these experiments was likely a result of activation-induced cell death. Bim has been reported to be involved in the induction of activation-induced cell death, 31 although its role in driving T-cell death in response to cytokine deprivation is more extensively understood. 11, 13 We have also characterized the role of Bim in cytokine deprivation-induced T-cell death and confirmed that both CD4 and CD8 T cells from Bim −/− mice are protected from this form of cell death. Interestingly, a partial reduction in Bim expression, as occurs in Bim +/− mice, did not inhibit CD4 T-cell death indicative of Bim haplosufficiency. CD8 T cells from Bim +/− mice underwent cell death at an intermediate level between the Bim −/− and the Bim +/+ CD8 T cells. This cell death pathway may regulate T-cell death in organ transplantation because graft-derived professional antigen-presenting cells that directly present alloantigens to T cells are eliminated as allogeneic immune responses progress over time and this may result in localized regions in which graft-reactive T cells experience a paucity of survival signals. 32, 33 Also, downregulation of certain cytokine receptors, such as CD25 and CD127, by effector T cells may render them unable to respond to survival signals even in settings of persistent antigen. 34 An unexpected role for Bim in regulating T-cell activation has been reported recently in animal models of autoimmune encephalomyelitis, type 1 diabetes mellitus, and graft-versus-host disease. 15, 16 However, the interplay between the regulation of T-cell activation and death by Bim was not examined in these studies. Our findings extend existing knowledge by establishing (1) a role for Bim in controlling both the activation and the death of T cells in response to alloantigen stimulation, (2) that a partial reduction of Bim expression inhibits T-cell proliferation without affecting CD4 T-cell death, for which complete elimination of Bim is necessary, and (3) that both processes control immune responses that lead to allograft vascular injury and rejection. It is important to note that, although Bim is required for certain types of clonal deletion in the thymus, 35 we did not observe splenomegaly in Bim +/− mice in our studies (data not shown). Also, systemic elimination of Bim has been reported to result in an increase in dysfunctional Foxp3-expressing T regs, 36 but we did not observe an increase in Foxp3-expressing T cells in Bim +/− or Bim −/− graft recipients (data not shown).
In our experiments, we observe an early defect in T-cell activation in the absence or reduced levels of Bim. Although we examined IL-2 secretion as a surrogate indicator of effector cytokine production in vitro, other cytokines are involved in supporting the expansion of effector T cells in the setting of transplantation in vivo. 37 Bim is likely to affect the acquisition of a large number of T-cell effector functions because it has been suggested to act proximally in TCR signaling pathways. 15 Ludwinski et al 15 reported that Bim −/− T cells activated with agonistic CD3 antibody had significantly reduced levels of calcium influx as compared with Bim +/+ T cells, and that this resulted in reduced activation of nuclear factor of activated T cells. Bcl-2 and Bcl-xL are known to localize to the endoplasmic reticulum and interact with the inositol 1,4,5 triphosphate receptor to either inhibit or potentiate calcium release. 38, 39 Given this, antagonism of Bcl-2 effects by Bim may serve to augment TCR-mediated calcium signaling in T cells. Further studies are needed to define these processes in T cells.
Our data establish that the reduction, but not the elimination, of Bim expression in graft recipients attenuates vascular injury and rejection. Partial reduction in Bim levels also resulted in reduced accumulation of effector CD4 T cells in the intima of allograft arteries and in reduced proliferation of alloreactive T cells but did not affect CD4 T-cell death. However, both T-cell activation and death were attenuated when Bim expression was completely absent in graft recipients. When assessed in combination with our in vitro findings, which show that Bim expression in T cells regulates T-cell activation and death in a similar manner, our data indicate that in the setting of Bim +/− graft recipients, CD4 T-cell activation is compromised but death is not, and this results in reduced allograft damage. However, when Bim expression is completely absent in Bim −/− recipients, attenuated T-cell activation is offset by increased survival of activated T cells and this results in no net effect on rejection. Interestingly, partial reduction of Bim levels in Bim +/− mice did not seem to affect CD8 T-cell accumulation in allograft arteries in our studies. In our studies, Bim is likely to affect vascular rejection through its actions in CD4 T cells because intimal thickening in complete MHC-mismatched aortic interposition grafts depends mainly on this T-cell subset. 40 We have evaluated the effect of Bim on alloantigen-driven immune responses and associated allograft vascular injury using aortic interposition grafting across a complete MHC barrier. This is an antigen mismatch situation that is reflective of that which occurs in almost all heart transplants and permits a comprehensive evaluation of T-cell responses that are known to be involved in organ transplant rejection. This includes direct T-cell recognition and targeting of foreign peptide-MHC presented by graft-derived cells, indirect T-cell recognition and targeting of graft-derived alloantigens presented by recipient antigen-presenting cells, and CD4 T-cell-dependent antibodymediated targeting of foreign MHC molecules on vascular cell surfaces. 17 However, immune-mediated arterial damage is severe in this model. This results in the rapid population of the intima by smooth muscle cells that are derived from circulating stem cells from the recipient, 28 a feature different from that which occurs clinically where almost all of the intimal smooth muscle cells are of donor origin. 41 As such, our analysis is applicable to understanding the basic immune mechanisms that result in allograft vascular injury and rejection but the specific vascular cell responses that contribute to intimal thickening in our model are partially distinct from those that drive similar changes in a clinical setting. 17, 42 In summary, we have shown that Bim regulates alloimmune responses that lead to allograft vascular injury. This regulation is complex and involves the control of both T-cell activation and death, and these processes are differentially susceptible to reductions in Bim expression. Our findings have implications for understanding the regulation of immune responses in transplantation and may have clinical implications given the investigation of BH3 mimetics for therapeutic applications. 43 We have identified a new role for the cell death regulatory protein, Bim, in controlling alloantigen-induced T-cell activation and vascular injury in transplantation. We have also determined that Bim controls both T-cell activation and death in response to alloantigens and that the balance of the effect of Bim on these opposing cellular processes determines the outcome of immunopathological responses.
Significance
